Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis
Rheumatology, 09/18/09
Tat SK et al. – Human chondrocytes express and produce OPG, RANK and RANKL. OA chondrocyte treatment with catabolic factors pointed towards an increased biological effect of OPG. Interestingly, OPG appears to be involved in OA progression by increasing two catabolic factors involved in cartilage pathophysiology.
Methods- Expression was determined using real-time PCR, production of RANK and RANKL by flow cytometry and that of OPG by ELISA
- Modulation of these factors was determined upon treatment with IL-1?, TNF- and PGE2
- The functional consequences were examined following treatment with soluble RANKL or OPG-Fc (OPG without the heparin-binding domain)
- OPG, RANK and RANKL were expressed and produced by human chondrocytes
- Membranous RANK was produced only by an OA chondrocyte subpopulation (29%) localized throughout the cartilage
- The OPG/RANKL ratio was significantly (P = 0.05) reduced on the OA chondrocytes, whereas the RANK/RANKL ratio was significantly (P < 0.03) increased
- OPG and membranous RANKL levels were significantly enhanced by IL-1?, TNF- and PGE2, whereas membranous RANK was significantly increased only with IL-1?
- Administration of soluble RANKL had no effect on the OA chondrocytes
- However, addition of OPG-Fc significantly stimulated MMP-13 (P = 0.05) and protease-activated receptor-2 (PAR-2) (P < 0.04) production
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Hepatoprotective effect of TNF-alpha blockade in psoriatic arthritis: A cross-sectional study
Annals of Rheumatic Diseases, 11/09/09
Musculoskeletal manifestations in patients with malignant disease
Clinical Rheumatology, 11/13/09
The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: A prospective study
Arthritis & Rheumatism, 11/04/09
Today in Osteoarthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Osteoarthritis: A review of treatment options
Geriatrics, 10/21/09
Doxycycline for osteoarthritis of the knee or hip
Cochrane Reviews, 10/23/09
Effect of biomagnetic therapy versus physiotherapy for treatment of knee osteoarthritis: A randomized controlled trial
Journal of Rehabilitation Medicine, 11/20/09
Sponsor
Article Search
Sponsor


See Latest Articles


